MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW)

CUSIP: 58507N113

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / *W EXP 12/22/202
Total 13F shares
4,186,417
Share change
+566,368
Total reported value
$3,443,000
Price per share
$0.82
Number of holders
22
Value change
+$406,041
Number of buys
4
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 58507N113?
CUSIP 58507N113 identifies MTACW - MEDTECH ACQUISITION CORP - *W EXP 12/22/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW) as of Q3 2021

As of 30 Sep 2021, MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,186,417 shares. The largest 10 holders included BlackRock Inc., Magnetar Financial LLC, Park West Asset Management LLC, ARISTEIA CAPITAL LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Linden Advisors LP, Spring Creek Capital LLC, Polar Asset Management Partners Inc., Vestcor Inc, and Point72 Asset Management, L.P.. This page lists 22 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.